To investigate the relative contribution of APOE genotype to the risk for developing severe COVID-19, Kuo et al. analyzed case data from the UK Biobank (UKB) cohort (9), a study of 322,948 subjects of European ancestry, with a mean age of 68 years. Here, APOE is linked to COVID-19.